K. Kissel

Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)

Maxime Dougados, K. Kissel, Tom Sheeran et al. · Annals of the Rheumatic Diseases · 2012 · 285 citations · Full text

Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study

Maxime Dougados, K. Kissel, Philip G. Conaghan et al. · Annals of the Rheumatic Diseases · 2014 · 151 citations · Full text

Use of Diagnostic Categories in Urinary Cytology in Comparison with the Bladder Tumour Antigen (BTA) Test in Bladder Cancer Patients

M. Takashi, Ulrich Schenck, K. Kissel et al. · International Urology and Nephrology · 1999 · 19 citations

THU0093 Clinical, radiographic, and immunogenic effects after 1 year of tocilizumab (TCZ)-based treatment strategy with and without methotrexate (MTX) in RA: The act-ray study

Maxime Dougados, K. Kissel, Philip G. Conaghan et al. · Annals of the Rheumatic Diseases · 2012 · 10 citations

Double-Blind Study of Tocilizumab Plus Methotrexate Vs Tocilizumab Plus Placebo in Patients with Active Rheumatoid Arthritis Despite Prior Methotrexate : Progression of Structural Damage, Quality of Life, and Physical Function At 24 Weeks.

Maxime Dougados, K. Kissel, Howard Amital et al. · Data Archiving and Networked Services (DANS) · 2011 · 10 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +10